JEFFREY D FONTENOT

Allopathic & Osteopathic Physicians|Internal Medicine BROUSSARD, LA NPI 1346744570

General Payments — all program years on this page

$631.73

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 34
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $354.41 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $354.4120

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $21.091
2022 $16.041
2023 $240.1912
2024 $354.4120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086941287 Novartis Pharmaceuticals Corporation $13.96 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086941291 Novartis Pharmaceuticals Corporation $17.91 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086941293 Novartis Pharmaceuticals Corporation $16.82 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086941297 Novartis Pharmaceuticals Corporation $17.19 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086941301 Novartis Pharmaceuticals Corporation $16.41 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089511646 Currax Pharmaceuticals LLC $16.57 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092586849 Boston Scientific Corporation $25.26 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096925044 Novo Nordisk Inc $13.21 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097140208 Novo Nordisk Inc $13.77 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103741361 ABBVIE INC. $20.10 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103741363 ABBVIE INC. $23.02 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105786040 AstraZeneca Pharmaceuticals LP $13.62 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114439641 Exact Sciences Corporation $16.31 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114439644 Exact Sciences Corporation $19.09 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114439649 Exact Sciences Corporation $14.51 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114439652 Exact Sciences Corporation $21.71 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131819467 PFIZER INC. $23.65 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131864455 PFIZER INC. $16.20 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135054022 Lilly USA, LLC $17.17 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135057762 Lilly USA, LLC $17.93 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.